Health Technology Wales Ruth Louise Poole Senior Health Services Researcher Health Technology Wales Cardiac Services Review Day 14 November 2017 SWALEC Stadium, Cardiff
HTW origins Access to medical technologies in Wales (Dec 2014) A Health Technology Adoption Hub for Wales (Apr 2016) Velindre NHS Trust to host Renamed Health Technology Wales Technoleg Iechyd Cymru
HTW purpose To deliver a strategic, national approach to the identification, appraisal and adoption of new technologies into health and care settings Health technologies include: devices diagnostics procedures clinical interventions HTW covers non-medicines health technologies organisational interventions pharmaceuticals Assessing Value Optimising Use public health interventions
Learning from others
HTW partners Efficiency Through Technology Fund (ETTF) Bevan Exemplars Health Board Innovation initiatives Life Sciences Hub Evidence Based Procurement Board Surgical Materials Testing Laboratory (SMTL) National Institute for Health and Care Excellence (NICE) Liaison Group Academia and others
Health Technology Assessment (HTA International) Health problem HTA is a field of scientific research to inform policy and clinical decision making on the Patient issues Health technology introduction and use of health technologies Health HTA is a multidisciplinary field that addresses Technology the clinical, economic, organisational, social, legal, and ethical impacts of a health technology, considering its specific healthcare context as well as available alternatives Organisation issues Value Cost Clinical effectiveness effectiveness
HTW appraisal committees (HTW HTA) Assessment Group Methodological rigour Topic selection, review Evidence Assessment Reports, assurance of appraisal processes, identify development/commissioning/decommissioning opportunities, develop processes for industry engagement, evaluate uptake of HTW advice HTW Director (Chair) Chief Scientific Advisor for Health Patient representatives Welsh Health Shared Services Committee Academic Health Service Partnership Swansea Centre for Health Economics Cedar Health Technology Research Centre Individual specialists Appraisal Panel Insights from NHS Wales Horizon scanning, consider implications of appraisal results for decision-makers, agree final HTW appraisal outputs, evaluate impact of evidence-based guidance, advise on stakeholder engagement Clinical Chair (appointed by open competition) HTW Director Directors of peer groups from all Health Boards in Wales Patient representatives Industry representatives Welsh Government
HTW appraisal process Informal enquiry Assessment Group review Decision- Makers Summary Topic proposal form Expert review Appraisal Panel review Topic exploration & scoping Evidence Appraisal Report Publish online
Topic proposal Anyone can complete the topic proposal form 15 questions Available online at www.healthtechnology.wales Topic proposer presents to HTW Assessment Group and joins in discussion High level exploration of published HTAs Clear topic selection criteria based on questions for NHS Wales and availability of evidence to appraise
Criteria for evaluating potential appraisal topics ALL OF: ONE OF: Likely impact on NHS resources Clear benefits to patients or NHS Current potential for quality improvement Uncertainty about clinical or costeffectiveness Focused appraisal questions can be Variation in provision or outcome asked across Wales Sufficient published research findings Supports prudent healthcare No recent NICE MTEP guidance
Appraisals currently underway Mechanical chest compression for use by the ambulance service for adults with out-ofhospital cardiac arrest WAST Epithelium-off corneal crosslinking for adults with keratoconus WHSSC (IPFRs) Appraisal topics not taken forward (insufficient evidence) Transapical transcatheter mitral valve-in-valve implantation for mitral valve repair in patients with a failed surgically-implanted mitral valve bioprosthesis Cardiac Network
Diverted appraisals From Cardiac Network: Leadless pacemakers for patients with bradycardia requiring augmentation with a pacemaker for a single chamber James Barry to be invited as stakeholder for NICE IP guidance Left atrial appendage occluder in patients with atrial fibrillation and a contraindication to oral anticoagulation Awaiting Commissioning through Evaluation report from NHS England Advice received from HCRW RDCS trial in NHS Wales Telemonitoring with pacemakers for disease management of patients with heart failure Workshop on adoption
HTW workshop & launch Telemonitoring with pacemakers for disease management of patients with heart failure in NHS Wales Date 27 November 2017 Time 9.00 am to 2.00 pm Location Life Sciences Hub, Cardiff Bay Registration via Eventbrite What pacemaker telemonitoring technologies are available to the NHS in Wales? How can we manage patients disease with pacemaker telemonitoring? What have colleagues learned from using pacemaker telemonitoring in their organisations?
Thank you Diolch Ruth.Poole2@wales.nhs.uk @healthtechwales healthtechnology.wales - Online topic proposal form 029 2019 6161 - Workshop registration information